Avadel Pharmaceuticals plc(AVDL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AVDL Avadel Pharmaceuticals plc

Post-Mkt 01-06 17:30:08 EST

21.50

+0.00

0.00%

盘后21.50

+0.000.00%

16:50 EST

High21.52	Low21.46	Vol1.30M
Open21.48	D1 Closing21.50	Amplitude0.26%
Mkt Cap2.11B	Tradable Cap1.73B	Total Shares98.15M
T/O28.00M	T/O Rate1.62%	Tradable Shares80.64M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AVDL","market":"US","secType":"STK","nameCN":"Avadel Pharmaceuticals plc","latestPrice":21.5,"timestamp":1767733200000,"preClose":21.5,"halted":0,"volume":1302807,"hourTrading":{"tag":"盘后","latestPrice":21.5,"preClose":21.5,"latestTime":"16:50 EST","volume":17526,"amount":376808.859792,"timestamp":1767736222635},"delay":0,"floatShares":80642958,"shares":98153471,"eps":-0.002874,"marketStatus":"Post-Mkt","change":0,"latestTime":"01-06 17:30:08 EST","open":21.48,"high":21.515,"low":21.46,"amount":28001266.026789002,"amplitude":0.002558,"askPrice":21.9,"askSize":400,"bidPrice":21.45,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.002874,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1767747600000},"marketStatusCode":4,"adr":1,"adrRate":1,"exchange":"NASDAQ","adjPreClose":21.5,"preHourTrading":{"tag":"盘前","latestPrice":21.48,"preClose":21.5,"latestTime":"09:29 EST","volume":3322,"amount":72003.655702,"timestamp":1767709799918},"postHourTrading":{"tag":"盘后","latestPrice":21.5,"preClose":21.5,"latestTime":"16:50 EST","volume":17526,"amount":376808.859792,"timestamp":1767736222635},"volumeRatio":1.808299,"impliedVol":0.5744,"impliedVolPercentile":0.364},"requestUrl":"/m/hq/s/AVDL/tweets","defaultTab":"tweets","newsList":[{"id":"2592179153","title":"Assessing Avadel Pharmaceuticals (AVDL) Valuation After a Strong 1-Year Share Price Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2592179153","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592179153?lang=en_us&edition=fundamental","pubTime":"2025-12-19 13:19","pubTimestamp":1766121546,"startTime":"0","endTime":"0","summary":"Avadel Pharmaceuticals (AVDL) has quietly turned into one of those under the radar movers, with the stock nearly doubling this year even after a recent pullback over the past month.\nSee our latest analysis for Avadel Pharmaceuticals.\nWith the share price now at $21.42, Avadel’s roughly 32% 3 month share price return and 107.76% 1 year total shareholder return suggest momentum is still building as investors reassess its growth runway and risk profile.\nIf Avadel’s run has you rethinking your...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-avdl/avadel-pharmaceuticals/news/assessing-avadel-pharmaceuticals-avdl-valuation-after-a-stro","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-avdl/avadel-pharmaceuticals/news/assessing-avadel-pharmaceuticals-avdl-valuation-after-a-stro","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK4007","AVDL"],"gpt_icon":0},{"id":"2592908419","title":"Avadel Pharmaceuticals Completes Enrollment in Phase 3 Trial of LUMRYZ for Idiopathic Hypersomnia","url":"https://stock-news.laohu8.com/highlight/detail?id=2592908419","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592908419?lang=en_us&edition=fundamental","pubTime":"2025-12-18 20:01","pubTimestamp":1766059292,"startTime":"0","endTime":"0","summary":"Avadel Pharmaceuticals plc announced the completion of patient enrollment in the Phase 3 REVITALYZ trial, which is evaluating LUMRYZ  extended-release oral suspension as a potential treatment for idiopathic hypersomnia. The study is a double-blind, placebo-controlled, randomized withdrawal, multicenter trial assessing both patients switching from immediate-release oxybates and those not currently taking oxybates. The primary endpoint is the change in total score on the Epworth Sleepiness Scale at Week 14, with secondary endpoints evaluating additional efficacy measures. Data from the trial are expected in the second quarter of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avadel Pharmaceuticals plc published the original content","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL8XG4L1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014013.SGD","LU2210150020.SGD","SG9999014021.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU0314104364.USD","NDAQ","SG9999014005.SGD","BK4112","IE00B3QW5Z07.USD","LU2095319765.USD","LU2210149790.SGD","BK4007","IE00BKPKM429.USD","BK4585","BK4588","AVDL"],"gpt_icon":0},{"id":"2592908618","title":"Avadel Pharmaceuticals Announces Completion of Enrollment in Phase 3 Revitalyz™ Trial in Idiopathic Hypersomnia","url":"https://stock-news.laohu8.com/highlight/detail?id=2592908618","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592908618?lang=en_us&edition=fundamental","pubTime":"2025-12-18 20:00","pubTimestamp":1766059200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nTUA8KD58W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AVDL"],"gpt_icon":0},{"id":"2592908112","title":"Avadel Pharmaceuticals Plc - Data Expected in Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2592908112","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592908112?lang=en_us&edition=fundamental","pubTime":"2025-12-18 20:00","pubTimestamp":1766059200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nTUA8KD58W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVDL","BK4007"],"gpt_icon":0},{"id":"2590248523","title":"HSR Waiting Period Expires for Avadel Pharmaceuticals Acquisition by Alkermes","url":"https://stock-news.laohu8.com/highlight/detail?id=2590248523","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590248523?lang=en_us&edition=fundamental","pubTime":"2025-12-10 05:16","pubTimestamp":1765315000,"startTime":"0","endTime":"0","summary":"Avadel Pharmaceuticals plc disclosed that the waiting period for regulatory review has expired regarding the planned acquisition of Avadel by Alkermes plc. This development marks the satisfaction of a key condition for the closing of the transaction. Completion of the acquisition remains subject to additional customary conditions, including approval by Avadel shareholders and final approval by the Irish High Court.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avadel Pharmaceuticals plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 09, 2025, and is solely responsible for the i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL3mMz2p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AVDL","ALKS","BK4139"],"gpt_icon":0},{"id":"2588228210","title":"Press Release: Announcement relating to despatch of Definitive Proxy Statement and details of Scheme Meeting and Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2588228210","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588228210?lang=en_us&edition=fundamental","pubTime":"2025-12-04 05:47","pubTimestamp":1764798420,"startTime":"0","endTime":"0","summary":"DUBLIN, Dec. 03, 2025  -- As previously announced, the board of directors of Avadel Pharmaceuticals plc , a public limited company incorporated in Ireland  and the board of directors of Alkermes plc, a public limited company incorporated in Ireland , reached agreement on the terms of an offer for the Company by Alkermes, pursuant to which Alkermes will acquire the entire issued and to be issued ordinary share capital of the Company . As outlined in both the announcement made by the Company and Alkermes under Rule 2.7 of the Irish Takeover Rules on October 22, 2025, and in the revised offer announcement made by the Company and Alkermes on November 19, 2025, the Proposed Transaction is to be implemented by way of a scheme of arrangement under Chapter 1 of Part 9 of the Irish Companies Act 2014 .Avadel Pharmaceuticals plc  is a biopharmaceutical company focused on transforming medicines to transform lives. Avadel's approach includes applying innovative solutions to the development of medi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["B","BK4017","BK4604","LU0345780521.USD","BK4007","BK4099","BK4161","BK4588","AVDL","LU0724618789.USD","LU0368265764.SGD","LU0788109121.HKD","LU0300736492.USD","LU0300736062.USD","BK4555","TM","LU0345780281.USD","LU0055631609.USD","LU1023059493.AUD","03160","BK4585","LU0788108826.HKD","LU0496367417.USD","LU0498741890.SGD","LU0330918003.SGD","LU0498741114.HKD","LU0075056555.USD"],"gpt_icon":0},{"id":"2588708036","title":"Avadel Pharmaceuticals Plc - Scheme Meeting and Egm Scheduled for January 12, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2588708036","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588708036?lang=en_us&edition=fundamental","pubTime":"2025-12-02 05:06","pubTimestamp":1764623185,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nFWN3X70R7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ALKS","AVDL","BK4139"],"gpt_icon":0},{"id":"2586370248","title":"BUZZ-H Lundbeck steps down from takeover for Avadel, shares rise 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586370248","media":"Reuters","labels":["shareholding","corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586370248?lang=en_us&edition=fundamental","pubTime":"2025-11-27 16:29","pubTimestamp":1764232155,"startTime":"0","endTime":"0","summary":"BUZZ-H Lundbeck steps down from takeover for Avadel, shares rise 3%** Shares in H Lundbeck HLUNa.CO rise 3.3% after the Danish pharmaceutical company said it would not increase a purchase price in a takeover offer for Avadel Pharmaceuticals AVDL.O ** Lundbeck added that its strategic rationale for engaging in the sleep disorders space stays \"fully intact\"** The Danish company made an unsolicited bid for Avadel on November 14, offering up to $23 per share** Drugmaker Alkermes ALKS.O, who also made a bid for Avadel, sweetened its offer to $2.37 billion, which Avadel's board recommended to its shareholders on November 19** H Lundbeck shares were up 1.3% at 08:27 GMT  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251127:nL8N3X30AF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALKS","BK4007","AVDL"],"gpt_icon":0},{"id":"2586260700","title":"Jefferies expects Avadel-Alkermes deal to close","url":"https://stock-news.laohu8.com/highlight/detail?id=2586260700","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586260700?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:05","pubTimestamp":1764191147,"startTime":"0","endTime":"0","summary":"Jefferies lowered the firm’s price target on Avadel Pharmaceuticals (AVDL) to $22.50 from $23 and keeps a Hold rating on the shares as the firm exp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jefferies-expects-avadel-alkermes-deal-to-close-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jefferies-expects-avadel-alkermes-deal-to-close-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","AVDL"],"gpt_icon":0},{"id":"2584389137","title":"Avadel Pharmaceuticals (AVDL) Gets a Hold from Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2584389137","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584389137?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:56","pubTimestamp":1763646967,"startTime":"0","endTime":"0","summary":"Wells Fargo analyst Benjamin Burnett maintained a Hold rating on Avadel Pharmaceuticals today and set a price target of $22.50. According to TipRan...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/avadel-pharmaceuticals-avdl-gets-a-hold-from-wells-fargo-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/avadel-pharmaceuticals-avdl-gets-a-hold-from-wells-fargo-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0048573561.USD","LU0052756011.USD","LU0251131958.USD","LU1074936037.SGD","LU0320765489.SGD","LU0267386448.USD","IE00B7SZLL34.SGD","LU0130102774.USD","LU2361044949.HKD","LU2361044865.SGD","LU2361045086.USD","BK4559","LU0251142724.SGD","LU0477156953.USD","LU0868494617.USD","LU0029864427.USD","IE00B19Z3B42.SGD","LU0130517989.USD","BK4588","LU0072461881.USD","LU0211327993.USD","LU0971096721.USD","LU1668664300.SGD","LU1201861249.SGD","LU0070302665.USD","LU0128525689.USD","LU0128525929.USD","LU0211328371.USD","LU0310800379.SGD","LU1069347547.HKD","LU2236285917.USD","LU0289960550.SGD","AVDL","LU0314106906.USD","LU1035773651.USD","LU1791807156.HKD","IE0002270589.USD","LU0708994859.HKD","LU0417517546.SGD","LU0942090050.USD","IE000M9KFDE8.USD","LU0162691827.USD","LU0208291251.USD","BK4501","LU0149725797.USD","LU1363072403.SGD","IE00B19Z3581.USD","LU0648001328.SGD","LU0154236417.USD","LU0980610538.SGD"],"gpt_icon":0},{"id":"2584630923","title":"Deals of the day-Mergers and acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2584630923","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584630923?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:00","pubTimestamp":1763568003,"startTime":"0","endTime":"0","summary":"Deals of the day-Mergers and acquisitionsAdds: Adobe, China International Capital Corp,  Alkermes Updates:September 19 (Reuters) - The following bids, mergers, acquisitions and disposals were reported","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nL6N3WV0U3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601059","LU0511384066.AUD","LU0433182093.SGD","LU0654597011.USD","BK4139","IE00B19Z9505.USD","LU0048584097.USD","601198","LU0861579265.USD","BK5159","IE00BYQQ9H92.USD","LU2089283258.USD","PSKY","01359","BK0009","LU1098665638.USD","LU0082616367.USD","AVDL","LU0068578508.USD","SHEL.UK","LU0889566641.SGD","LU1084165304.USD","BK1156","LU1580142542.USD","LU1242518857.USD","SEMR","ALKS","LU0368265418.SGD","BK4125","LU0964806797.USD","LU0965508806.USD","LU0211328371.USD","WBD","LU2458330169.SGD","LU1119994496.HKD","LU1934455277.USD","IE00BFXG0V08.USD","LU1267930573.SGD","BK4539","601995","LU0266512127.USD","LU0612318971.USD","ITH.UK","LU0708994859.HKD","LU1720051108.HKD","LU1366333091.USD","LU0006306889.USD","LU0719512351.SGD","LU0128525689.USD"],"gpt_icon":1},{"id":"2584928455","title":"Analysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL) and Oncolytics Biotech (ONCY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2584928455","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584928455?lang=en_us&edition=fundamental","pubTime":"2025-11-19 23:30","pubTimestamp":1763566219,"startTime":"0","endTime":"0","summary":"Analysts fell to the sidelines weighing in on Avadel Pharmaceuticals (AVDL – Research Report) and Oncolytics Biotech (ONCY – Research Report) with ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-avadel-pharmaceuticals-avdl-and-oncolytics-biotech-oncy-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-avadel-pharmaceuticals-avdl-and-oncolytics-biotech-oncy-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVDL","BK4137","BK4588","BK4139","LU0029874061.USD","XBI","BK4585","LABU","ONCY","BK4007","HCSG","XLV","LU0128526141.USD","BK4581"],"gpt_icon":0},{"id":"2584050942","title":"BRIEF-H Lundbeck A/S Says Noted That Our Offer For Acquiring Avadel No Longer Is Considered Superior By Their Board, We Are Currently Considering Our Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2584050942","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584050942?lang=en_us&edition=fundamental","pubTime":"2025-11-19 22:23","pubTimestamp":1763562212,"startTime":"0","endTime":"0","summary":"BRIEF-H Lundbeck A/S Says Noted That Our Offer For Acquiring Avadel No Longer Is Considered Superior By Their Board, We Are Currently Considering Our OptionsNov 19  - Alkermes Plc ALKS.O:H LUNDBECK A/S:  NOTED THAT OUR OFFER FOR ACQUIRING AVADEL NO LONGER IS CONSIDERED SUPERIOR BY THEIR BOARD, WE ARE CURRENTLY CONSIDERING OUR OPTIONSSource text: [ID:]Further company coverage: ALKS.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nFWN3WV0WP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALKS","BK4007","AVDL"],"gpt_icon":0},{"id":"2584941809","title":"H Lundbeck a/S:  Noted That Our Offer for Acquiring Avadel No Longer Is Considered Superior by Their Board, We Are Currently Considering Our Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2584941809","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584941809?lang=en_us&edition=fundamental","pubTime":"2025-11-19 21:08","pubTimestamp":1763557702,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nFWN3WV0WP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVDL","BK4139","ALKS","BK4007"],"gpt_icon":0},{"id":"2584435119","title":"Avadel Pharmaceuticals (AVDL) Receives a Hold from H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2584435119","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584435119?lang=en_us&edition=fundamental","pubTime":"2025-11-19 19:36","pubTimestamp":1763552206,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Ram Selvaraju reiterated a Hold rating on Avadel Pharmaceuticals today and set a price target of $20.00. According to TipRa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/avadel-pharmaceuticals-avdl-receives-a-hold-from-h-c-wainwright-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/avadel-pharmaceuticals-avdl-receives-a-hold-from-h-c-wainwright-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","AVDL"],"gpt_icon":0},{"id":"2584994800","title":"Avadel Pharmaceuticals Shares up 1.5% Premarket After Alkermes Raises Offer to Buy Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2584994800","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584994800?lang=en_us&edition=fundamental","pubTime":"2025-11-19 19:31","pubTimestamp":1763551897,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nL4N3WV0VK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVDL","BK4007"],"gpt_icon":0},{"id":"2584910084","title":"Alkermes Raises Offer to Acquire Avadel Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2584910084","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584910084?lang=en_us&edition=fundamental","pubTime":"2025-11-19 19:01","pubTimestamp":1763550068,"startTime":"0","endTime":"0","summary":"Alkermes plc has increased its offer to acquire Avadel Pharmaceuticals plc, matching the $21.00 per share cash consideration proposed in a competing bid from Lundbeck. According to Alkermes, the revised terms include a contingent value right  that is considered superior to that offered in the Lundbeck proposal, which Avadel's board determined was unlikely to be achieved. Following a review with its advisors, Avadel's board concluded that the Alkermes offer is now more favorable than the Lundbeck proposal. Financial and legal advisors for both companies are involved in advancing the transaction, with J.P. Morgan providing fully committed financing to Alkermes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkermes plc published the ori","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDL7wZ42K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","AVDL","BK4007","BK4139"],"gpt_icon":0},{"id":"2584948867","title":"Alkermes: Proposed Deal Consideration Consists of $21.00 in Cash and One Non-Transferable CVR for Potential Additional Cash Payment of $1.50/Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2584948867","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584948867?lang=en_us&edition=fundamental","pubTime":"2025-11-19 19:00","pubTimestamp":1763550000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nTUA67XLCB:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ALKS","AVDL","BK4139"],"gpt_icon":0},{"id":"2584910799","title":"Alkermes Plc - Deal Valued up to $22.50 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2584910799","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584910799?lang=en_us&edition=fundamental","pubTime":"2025-11-19 19:00","pubTimestamp":1763550000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nTUA67XLCB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALKS","BK4007","AVDL"],"gpt_icon":0},{"id":"2584910743","title":"Alkermes Plc Announces Increased Offer to Acquire Avadel Pharmaceuticals Plc","url":"https://stock-news.laohu8.com/highlight/detail?id=2584910743","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584910743?lang=en_us&edition=fundamental","pubTime":"2025-11-19 19:00","pubTimestamp":1763550000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nTUA67XLCB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVDL","BK4139","ALKS","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.avadel.com","stockEarnings":[{"period":"1week","weight":-0.0023},{"period":"1month","weight":0.0075},{"period":"3month","weight":0.4858},{"period":"6month","weight":1.2513},{"period":"1year","weight":0.9439},{"period":"ytd","weight":-0.0023}],"compareEarnings":[{"period":"1week","weight":-0.0002},{"period":"1month","weight":0.003},{"period":"3month","weight":0.0278},{"period":"6month","weight":0.102},{"period":"1year","weight":0.1618},{"period":"ytd","weight":0.0085}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.","yearOnYearQuotes":[{"month":1,"riseRate":0.566667,"avgChangeRate":0.047783},{"month":2,"riseRate":0.482759,"avgChangeRate":0.098928},{"month":3,"riseRate":0.448276,"avgChangeRate":-0.017439},{"month":4,"riseRate":0.482759,"avgChangeRate":0.020678},{"month":5,"riseRate":0.517241,"avgChangeRate":-0.004725},{"month":6,"riseRate":0.448276,"avgChangeRate":0.040203},{"month":7,"riseRate":0.4,"avgChangeRate":0.022136},{"month":8,"riseRate":0.433333,"avgChangeRate":0.041512},{"month":9,"riseRate":0.366667,"avgChangeRate":-0.024246},{"month":10,"riseRate":0.4,"avgChangeRate":0.008337},{"month":11,"riseRate":0.533333,"avgChangeRate":0.055436},{"month":12,"riseRate":0.482759,"avgChangeRate":0.035745}],"exchange":"NASDAQ","name":"Avadel Pharmaceuticals plc","nameEN":"Avadel Pharmaceuticals plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Avadel Pharmaceuticals plc(AVDL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Avadel Pharmaceuticals plc(AVDL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Avadel Pharmaceuticals plc,AVDL,Avadel Pharmaceuticals plc股票,Avadel Pharmaceuticals plc股票老虎,Avadel Pharmaceuticals plc股票老虎国际,Avadel Pharmaceuticals plc行情,Avadel Pharmaceuticals plc股票行情,Avadel Pharmaceuticals plc股价,Avadel Pharmaceuticals plc股市,Avadel Pharmaceuticals plc股票价格,Avadel Pharmaceuticals plc股票交易,Avadel Pharmaceuticals plc股票购买,Avadel Pharmaceuticals plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Avadel Pharmaceuticals plc(AVDL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Avadel Pharmaceuticals plc(AVDL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction